Compare ROG & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROG | AGIO |
|---|---|---|
| Founded | 1832 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 1994 | 2013 |
| Metric | ROG | AGIO |
|---|---|---|
| Price | $142.83 | $33.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $133.00 | $38.88 |
| AVG Volume (30 Days) | 230.2K | ★ 1.2M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $879,091,000.00 | $43,011,000.00 |
| Revenue This Year | $7.64 | $76.75 |
| Revenue Next Year | $6.09 | $170.73 |
| P/E Ratio | $550.84 | ★ N/A |
| Revenue Growth | ★ 7.07 | N/A |
| 52 Week Low | $72.49 | $22.24 |
| 52 Week High | $169.00 | $46.00 |
| Indicator | ROG | AGIO |
|---|---|---|
| Relative Strength Index (RSI) | 58.32 | 45.72 |
| Support Level | $130.83 | $26.16 |
| Resistance Level | $144.46 | $36.07 |
| Average True Range (ATR) | 5.79 | 1.79 |
| MACD | 2.19 | 0.01 |
| Stochastic Oscillator | 95.57 | 50.06 |
Rogers Corp designs develop and manufactures engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.